Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Research in preclinical models suggests that AOD 9604 may support lipolysis by upregulating beta-3 adrenergic receptor expression and inhibiting new fat cell formation, with human trial data confirming no IGF-1 elevation or glucose disruption [2, 3]
[1] [3] The unique aspect of this formulation lies in its high concentration and the option for preservative-free preparation, which may be suitable for patients with sensitivities or allergies to common preservatives
The association between polymorphisms of GST genes and the risk of epilepsy has been investigated in several studies 60,61,62
L., & Soulage, C
US$ 27.15
US$ 21.01
US$ 26.35
US$ 27.17
US$ 20.97
